Advertisement

Advertisement

AU:FRE Stock Latest News

Firebrick Pharma Calls Virtual Meeting to Ratify Key Share and Option Issues

Company AnnouncementsFirebrick Pharma Calls Virtual Meeting to Ratify Key Share and Option Issues

Firebrick Pharma Director Increases Indirect Shareholding via On-Market Purchase

PremiumCompany Announcements

Firebrick Pharma Director Increases Indirect Shareholding via On-Market Purchase

2d ago

Firebrick Pharma wins Canadian patent for Nasodine COVID-19 use

PremiumCompany Announcements

Firebrick Pharma wins Canadian patent for Nasodine COVID-19 use

10d ago

Firebrick Pharma to Brief Investors After Nasodine Approval and $1.5m Placement

PremiumCompany Announcements

Firebrick Pharma to Brief Investors After Nasodine Approval and $1.5m Placement

1M ago

Firebrick Pharma ramps up Nasodine rollout and global push with new capital and hires

PremiumCompany Announcements

Firebrick Pharma ramps up Nasodine rollout and global push with new capital and hires

1M ago

Firebrick Pharma Issues 6.38 Million Unquoted Options Expiring 2028

PremiumCompany AnnouncementsFirebrick Pharma Issues 6.38 Million Unquoted Options Expiring 2028

1M ago

Firebrick Pharma Investor Goodall Sees Voting Power Diluted After Private Placement

Company Announcements

Firebrick Pharma Investor Goodall Sees Voting Power Diluted After Private Placement

1M ago

Firebrick Pharma Private Placement Dilutes Major Shareholder’s Voting Power

Company Announcements

Firebrick Pharma Private Placement Dilutes Major Shareholder’s Voting Power

1M ago

Firebrick Pharma Issues 1 Million Unlisted Employee Options

PremiumCompany Announcements

Firebrick Pharma Issues 1 Million Unlisted Employee Options

1M ago

Firebrick Pharma Seeks ASX Quotation for Over 10.6 Million New Shares

PremiumCompany Announcements

Firebrick Pharma Seeks ASX Quotation for Over 10.6 Million New Shares

1M ago

Firebrick Pharma Announces Expiry of 180,000 Unexercised Options

PremiumCompany Announcements

Firebrick Pharma Announces Expiry of 180,000 Unexercised Options

1M ago

Firebrick Pharma Issues Over 21.6 Million New Shares and Confirms Regulatory Compliance

PremiumCompany Announcements

Firebrick Pharma Issues Over 21.6 Million New Shares and Confirms Regulatory Compliance

1M ago

Firebrick Pharma Issues 10.6 Million Unquoted Options Expiring in 2028

PremiumCompany AnnouncementsFirebrick Pharma Issues 10.6 Million Unquoted Options Expiring in 2028

1M ago

Firebrick Pharma Applies to Quote 21.3 Million New Shares on ASX

Company Announcements

Firebrick Pharma Applies to Quote 21.3 Million New Shares on ASX

1M ago

Firebrick Pharma Seeks Quotation of 360,000 New Ordinary Shares on ASX

Company Announcements

Firebrick Pharma Seeks Quotation of 360,000 New Ordinary Shares on ASX

1M ago

Firebrick Pharma Raises $1.5m to Fund Nasodine Expansion and New Products

PremiumCompany Announcements

Firebrick Pharma Raises $1.5m to Fund Nasodine Expansion and New Products

2M ago

Firebrick Pharma Seeks ASX Trading Halt Ahead of Placement Announcement

PremiumCompany Announcements

Firebrick Pharma Seeks ASX Trading Halt Ahead of Placement Announcement

2M ago

Firebrick Pharma Wins First Nasodine Approval in Major Indonesian Market

PremiumCompany Announcements

Firebrick Pharma Wins First Nasodine Approval in Major Indonesian Market

2M ago

Firebrick Pharma to Showcase Nasodine Growth Strategy at NWR Virtual Healthcare Conference

PremiumCompany Announcements

Firebrick Pharma to Showcase Nasodine Growth Strategy at NWR Virtual Healthcare Conference

2M ago

Firebrick Pharma Secures Philippine Patent for Nasodine COVID-19 Use

PremiumCompany AnnouncementsFirebrick Pharma Secures Philippine Patent for Nasodine COVID-19 Use

2M ago

Firebrick Pharma hires veteran dealmaker to spearhead global Nasodine expansion

Company Announcements

Firebrick Pharma hires veteran dealmaker to spearhead global Nasodine expansion

2M ago

Firebrick Pharma targets global expansion as Nasodine sales surge in U.S. and Asia

Company Announcements

Firebrick Pharma targets global expansion as Nasodine sales surge in U.S. and Asia

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >